Xenon just delivered strong clinical trial results and leveraged that into a strong fundraising effort. That has XENE stock in a good place going forward.
The post Xenon: Heading Toward Phase III With Strong Momentum appeared first on InvestorPlace.
Xenon: Heading Toward Phase III With Strong Momentum
- by Ian Bezek
